Contact Us
We are international
-select-
Italiano
Français
中文
Español
Deutsch
Русский
日本語
Türkçe
Português
한국어
Polski
Ελληνικά
עִברִית
Čeština
اللغة العربية
Norske
Danske
Nederlands
हिंदी
Afrikaans
فارسی
հայերեն
Magyar
Donate
•about myeloma
newly diagnosed?
10 steps to better care®
caregivers
publications
•treatment options
frontline therapy
novel therapies
bone disease
stem cell transplant
treatment at relapse
clinical trials
supportive care
myeloma matrix
drugs In development
•health professionals
black swan research initiative™
clinical trials
international myeloma working group
imwg conference series
nurse leadership board
asian myeloma network
global clinical trials forum
webcasts
seminars & meetings
meeting highlights
kyle lifetime achievement award
• support
toll-free hotline
support groups
online group
• webcasts
#askdrdurie
webcasts from patient & family seminars
webcasts from medical meetings
imwg conference series
nlb webcasts
imf webcasts
imf international webcasts
teleconferences
webinars
• meetings
patient & family seminars
community workshops
international seminars
event calendar
• advocacy
IMF advocacy
advocacy update
become an advocate
action center
advocate of the month
public policy statements
latest news and info
contact us
• fundraising
FUNdraisers
make a donation
major giving
planned giving
tributes and memorials
annual comedy celebration
the hope society
1000 cranes of hope
fly a virtual kite
cell phones for a cure
shop for the imf
buy imf merchandise
donate your vehicle
contact development
• media
• blogs
myeloma voices
IMF at ASH 2012
• about imf
about us
people of IMF
international partners
imf funded research
media kit
dr. brian durie
chairman of the board
susie novis
president
media contact
• media
TEXT SIZE
archive
back
NEW DRUG COMBINATION - VELCADE® PLUS DOXIL® - APPROVED FOR MYELOMA
Combination Provides 43% Improvement in Time to Disease Progression
05.22.07
Be the first to comment
Name
Email Address
URL
Remember personal info?
Comments (You may use HTML tags for style)
print
share
|
related articles
We thank our website sponsors
Amgen
Binding Site
Celgene Corporation
Genentech
GSK Oncology
Onyx Pharmaceuticals
We welcome our international partners
Canada
China
Czech Republic
Europe
Israel
Italy
Japan
Latin America
back
print
Be the first to comment